[Clinical tests with a new antihypertensive combination (Bendigon)].
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use; D004338:Drug Combinations; D004357:Drug Synergism; D005069:Evaluation Studies as Topic; D005663:Furans / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007294:Inositol / Q000627:therapeutic use*; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D012110:Reserpine / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D004232:Diuretics; D004338:Drug Combinations; D005663:Furans; D009539:Nicotinic Acids; D013449:Sulfonamides; D007294:Inositol; D012110:Reserpine
Ergebnisse der klinischen Prüfung der neuen blutdrucksenkenden Wirkstoftkombination (Bendigon.